Robert G. Maki

Oncology
160 E 53rd St
New York, NY 10022

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 171 publications

Adjuvant treatment of gastrointestinal stromal tumors (GIST)-state of the art, controversies, and future directions.

Adjuvant treatment of gastrointestinal stromal tumors (GIST)-state of the art, controversies, and future directions.

Journal: ESMO gastrointestinal oncology
Published: September 03, 2026

Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience.

Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience.

Journal: European journal of cancer (Oxford, England : 1990)
Published: June 27, 2026

Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma.

Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma.

Journal: Journal for immunotherapy of cancer
Published: April 15, 2026

Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials.

Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials.

Journal: Cancer medicine
Published: April 08, 2026

Cancer Chemoimmunotherapy: Time Will Tell.

Cancer Chemoimmunotherapy: Time Will Tell.

Journal: Cancer immunology research
Published: March 18, 2026

Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 Trial.

Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 04, 2026

Molecular Profiling for Precision Oncology: Moving Beyond Feasibility and Safety.

Molecular Profiling for Precision Oncology: Moving Beyond Feasibility and Safety.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 14, 2026

Multi-Omic Landscape of Gastrointestinal Stromal Tumors in a Real-World Patient Cohort of 1,427 Cases.

Multi-Omic Landscape of Gastrointestinal Stromal Tumors in a Real-World Patient Cohort of 1,427 Cases.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 02, 2025

Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial.

Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial.

Journal: Nature medicine
Published: November 01, 2025

Real-World Experience of Efficacy and Tolerability of Continuous Infusion Ifosfamide for Advanced Soft Tissue and Bone Sarcoma Patients: A Single Centre Retrospective Cohort.

Real-World Experience of Efficacy and Tolerability of Continuous Infusion Ifosfamide for Advanced Soft Tissue and Bone Sarcoma Patients: A Single Centre Retrospective Cohort.

Journal: Cancer medicine
Published: September 18, 2025

Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma.

Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 10, 2025

NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in solitary fibrous tumors.

NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in solitary fibrous tumors.

Journal: eLife
Published: August 28, 2025
Showing 1-12 of 171

Last Updated: 09/26/2026